Increased 3H-Clonidine binding in the platelets of patients with depressive and Schizophrenic disorders
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 28 (1) , 73-88
- https://doi.org/10.1016/0165-1781(89)90199-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patientsLife Sciences, 1987
- Evaluation of studies on platelet alpha2 adrenoreceptors in depressive illnessLife Sciences, 1986
- Prophylactic lithium treatment of patients with affective disorders is associated with decreased platelet [3H] dihydroergocryptine bindingJournal of Affective Disorders, 1983
- Hypersensitivity of Adrenergic Receptors and Blood-Pressure Response to Oral Yohimbine in Orthostatic HypotensionNew England Journal of Medicine, 1983
- Schizophrenia and reduced cyclic AMP production: Evidence for the role of receptor-linked eventsLife Sciences, 1982
- Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbineLife Sciences, 1982
- α2-adrenergic receptors in platelet membranes of depressed patients: No change in number of 3H-yohimbine affinityLife Sciences, 1981
- Human platelet α2-adrenergic receptors: Labeling with 3H-yohimbine, a selective antagonist ligandLife Sciences, 1981
- Growth Hormone and other Responses to Clonidine in Patients with Endogenous DepressionThe British Journal of Psychiatry, 1981
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949